Ikena Oncology Inc.
13F holders, Q3 2024 (September 30)57holders −13
5new positions
18sold out
3famous investors
$1.73avg. 13F price*
At the end of Q3 2024, 57 institutions reported holding Ikena Oncology Inc. in their 13F filings, down 13 from Q2 2024. 5 opened new positions and 18 sold out. The largest holders were Atlas Venture Life Science Advisors, LLC ($8.7M), BVF Inc. ($8.3M) and Blue Owl Capital Holdings LP ($7.1M). 3 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio), Israel Englander (0.0% of Millennium Management's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Ikena Oncology Inc.
- CUSIP
- 45175G108
- Latest filing quarter
- Q2 2025
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $711K |
| Exits | 18 | $929K |
All 13F filers, Q2 2024 → Q3 2024: 900,013 shares bought and 1,498,214 shares sold, net −598,201 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 57 holders
| Atlas Venture Life Science Advisors, LLC | 0.80% | No change | 5,018,178 | $8.7M |
| BVF Inc. | 0.24% | No change | 4,769,164 | $8.3M |
| Blue Owl Capital Holdings LP | 1.38% | No change | 4,091,118 | $7.1M |
| Orbimed Advisors LLC | 0.11% | No change | 3,539,358 | $6.1M |
| Omega Fund Management, LLC | 2.43% | No change | 2,249,123 | $3.9M |
| Vanguard Group Inc. | 0.00% | Add +1.5% | 1,384,664 | $2.4M |
| Adage Capital Partners Gp, L.L.C. | 0.00% | No change | 987,900 | $1.7M |
| BML Capital Management, LLC | 0.74% | Add +23.6% | 723,288 | $1.3M |
| NEA Management Company, LLC | 0.06% | Add +5.3% | 600,063 | $1.0M |
| Acuitas Investments, LLC | 0.35% | Add +12.4% | 449,656 | $778K |
| Renaissance Technologies | 0.00% | Reduce -15.9% | 400,600 | $693K |
| Jacobs Levy Equity Management, Inc. | 0.00% | Reduce -8.4% | 388,748 | $673K |
| Sofinnova Investments, Inc. | 0.05% | No change | 382,616 | $662K |
| BlackRock, Inc. | 0.00% | — | 352,176 | $609K |
| Acadian Asset Management LLC | 0.00% | No change | 325,713 | $562K |
| Geode Capital Management, LLC | 0.00% | Add +5.6% | 271,026 | $469K |
| Millennium Management | 0.00% | Reduce -29.7% | 249,417 | $431K |
| FNY Investment Advisers, LLC | 0.19% | New | 231,383 | $400K |
| Two Sigma Advisers, LP | 0.00% | Add +16.7% | 202,100 | $350K |
| Barclays PLC | 0.00% | Reduce -0.4% | 195,311 | $338K |
| Citadel Advisors | 0.00% | Reduce -32.6% | 165,015 | $285K |
| Bridgeway Capital Management, LLC | 0.01% | Add +92.5% | 158,400 | $274K |
| Two Sigma Investments, LP | 0.00% | Reduce -33.8% | 156,713 | $271K |
| BBR Partners, LLC | 0.02% | Add +550.0% | 130,000 | $225K |
| Vazirani Asset Management LLC | 0.36% | New | 115,668 | $200K |
| Deuterium Capital Management, LLC | 0.26% | Add +0.0% | 80,579 | $139K |
| State Street Corp. | 0.00% | No change | 80,353 | $139K |
| Marquette Asset Management, LLC | 0.02% | No change | 72,890 | $126K |
| JBF Capital, Inc. | 0.02% | No change | 72,647 | $126K |
| Goldman Sachs Group Inc. | 0.00% | Reduce -78.6% | 58,623 | $101K |
| Susquehanna International Group, LLP | 0.00% | Reduce -31.4% | 57,090 | $99K |
| Prelude Capital Management, LLC | 0.01% | New | 50,638 | $88K |
| Northern Trust Corp. | 0.00% | Reduce -77.8% | 48,109 | $83K |
| ADAR1 Capital Management, LLC | 0.01% | Reduce -4.4% | 44,635 | $77K |
| Dimensional Fund Advisors LP | 0.00% | No change | 38,621 | $67K |
| FMR LLC | 0.00% | Add +94.1% | 38,374 | $66K |
| Jane Street Group, LLC | 0.00% | Reduce -33.3% | 37,270 | $64K |
| Prudential Financial Inc. | 0.00% | No change | 29,800 | $52K |
| Corsair Capital Management, L.P. | 0.01% | No change | 24,830 | $43K |
| Point72 Asia (Singapore) Pte. Ltd. | 0.01% | Reduce -51.4% | 22,146 | $38K |
| Berkshire Asset Management LLC | 0.00% | No change | 20,000 | $33K |
| Vanguard Personalized Indexing Management, LLC | 0.00% | Reduce -2.8% | 17,795 | $31K |
| Qube Research & Technologies Ltd | 0.00% | Reduce -50.3% | 17,352 | $30K |
| Morgan Stanley | 0.00% | Reduce -62.3% | 15,403 | $27K |
| Charles Schwab Investment Management Inc. | 0.00% | No change | 12,066 | $21K |
| LPL Financial LLC | 0.00% | New | 12,000 | $21K |
| Point72 (DIFC) Ltd | 0.00% | Add +52.9% | 6,716 | $12K |
| Catalyst Funds Management Pty Ltd | 0.00% | No change | 4,500 | $8K |
| Russell Investments Group, Ltd. | 0.00% | Add +17.8% | 2,728 | $5K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -90.7% | 1,875 | $3K |
| Osaic Holdings, Inc. | 0.00% | New | 1,503 | $3K |
| JPMorgan Chase & Co. | 0.00% | No change | 849 | $1K |
| Arax Advisory Partners | 0.00% | No change | 299 | $518 |
| Bank of America Corp. | 0.00% | Reduce -39.1% | 199 | $344 |
| Farther Finance Advisors, LLC | 0.00% | Reduce -36.5% | 108 | $187 |
| Nisa Investment Advisors, LLC | 0.00% | No change | 99 | $171 |
| UBS Group AG | 0.00% | Reduce -99.8% | 72 | $125 |
"% of holder's portfolio" is IKENA ONCOLOGY INC's weight in each manager's 13F, not the share of Ikena Oncology Inc. the manager owns.